Meenakshisundaram Kandhavelu

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Radical Prostatectomy

Prostate Cancer

Molecular Docking

Top Venues

Journal of biomolecular structure & dynamics

Apoptosis : an international journal on programmed cell death

Future medicinal chemistry

Journal of cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Saravanan Konda Mani, Ramesh Thiyagarajan, Olli Yli-Harja, Meenakshisundaram Kandhavelu, Akshaya Murugesan
Structural analysis of human G-protein-coupled receptor 17 ligand binding sites. Journal of cellular biochemistry (2023)
Jeyalakshmi Kandhavelu, Kumar Subramanian, Vivash Naidoo, Giulia Sebastianelli, Phuong Doan, Saravanan Konda Mani, Hande Yapislar, Ebru Haciosmanoglu, Leman Arslan, Samed Ozer, Ramesh Thiyagarajan, Nuno R Candeias, Clement Penny, Meenakshisundaram Kandhavelu, Akshaya Murugesan
A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer. British journal of pharmacology (2023)
Gnanavel Mutharasu, Akshaya Murugesan, Saravanan Konda Mani, Thiyagarajan Ramesh, Olli Yli-Harja, Meenakshisundaram Kandhavelu
Signaling landscape of mitochondrial non-coding RNAs. Journal of biomolecular structure & dynamics (2023)
Hien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, Thiyagarajan Ramesh, Olli Yli-Harja, Meenakshisundaram Kandhavelu
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer. Apoptosis : an international journal on programmed cell death 27 (3-4) (2022)
Sana Kari, Kumar Subramanian, Ilenia Agata Altomonte, Akshaya Murugesan, Olli Yli-Harja, Meenakshisundaram Kandhavelu
Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis : an international journal on programmed cell death 27 (7-8) (2022)
Suresh Palanivel, Olli Yli-Harja, Meenakshisundaram Kandhavelu
Molecular interaction study of novel indoline derivatives with EGFR-kinase domain using multiple computational analysis. Journal of biomolecular structure & dynamics (2021)
Phung Nguyen, Phuong Doan, Tatu Rimpilainen, Saravanan Konda Mani, Akshaya Murugesan, Olli Yli-Harja, Nuno R Candeias, Meenakshisundaram Kandhavelu
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment. Journal of medicinal chemistry 64 (15) (2021)
Hien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, Olli Yli-Harja, Meenakshisundaram Kandhavelu
Functional characterization of HIC, a P2Y1 agonist, as a p53 stabilizer for prostate cancer cell death induction. Future medicinal chemistry 13 (21) (2021)
Akshaya Murugesan, Phung Nguyen, Thiyagarajan Ramesh, Olli Yli-Harja, Meenakshisundaram Kandhavelu, Saravanan Konda Mani
Molecular modeling and dynamics studies of the synthetic small molecule agonists with GPR17 and P2Y1 receptor. Journal of biomolecular structure & dynamics (2021)
Akshaya Murugesan, Suvi Holmstedt, Kenna C Brown, Alisa Koivuporras, Ana S Macedo, Nga Nguyen, Pedro Fonte, Patrícia Rijo, Olli Yli-Harja, Nuno R Candeias, Meenakshisundaram Kandhavelu
Design and synthesis of novel quinic acid derivatives: in vitro cytotoxicity and anticancer effect on glioblastoma. Future medicinal chemistry 12 (21) (2020)
Gnanavel Mutharasu, Akshaya Murugesan, Saravanan Konda Mani, Olli Yli-Harja, Meenakshisundaram Kandhavelu
Transcriptomic analysis of glioblastoma multiforme providing new insights into GPR17 signaling communication. Journal of biomolecular structure & dynamics (2020)
Hien Thi Thu Le, Tatu Rimpilainen, Saravanan Konda Mani, Akshaya Murugesan, Olli Yli-Harja, Nuno R Candeias, Meenakshisundaram Kandhavelu
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. Scientific reports 9 (1) (2019)